Investigating the effect of Attentalin in children with hyperactivity attention deficit disorder
Phase 3
Recruiting
- Conditions
- Hyperactivity attention deficit disorder.Attention-deficit hyperactivity disorder, predominantly inattentive typeF90.0
- Registration Number
- IRCT20240520061849N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 108
Inclusion Criteria
Patients with attention deficit hyperactivity disorder
Informed consent of the patient's parents or legal guardian to participate in the study
Children 6 to 9 years old
Exclusion Criteria
History of drug side effects after taking Attentalin
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method